|
|
||||||||
American Journal of Clinical Nutrition, Vol 48, 1443-1444, Copyright © 1988 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
R Carmel
Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.
An increased risk of early, sudden death after treatment of megaloblastic anemia has been reported. This was particularly true for severe anemia, with a mortality rate of 14%. Because no other investigations of this phenomenon have been done since these alarming findings, the experience at our medical center was reviewed. Of 219 patients with pernicious anemia, 101 had severe anemia (hemoglobin less than or equal to 80 g/L). None of the severely anemic patients died during hospitalization. Only one death occurred among all 219 patients and this death was not unexpected but attributable to coexisting diseases. Pernicious anemia, even when severe, is not associated with increased mortality after therapy.
This article has been cited by other articles:
![]() |
R. Carmel How I treat cobalamin (vitamin B12) deficiency Blood, September 15, 2008; 112(6): 2214 - 2221. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |